Alkem Laboratories (Alkem) has announced the expansion of its nationwide initiative, Reliever Free India, with up to 700 camps across India. Collaborating with nearly 100 hospitals in tier-1 and tier-2 cities, the initiative was launched in 2023 to shift the focus from reliever medications to controller medications in asthma management.
Asthma, affecting 26.20 crore people globally, remains a major challenge despite medical advancements. Acknowledging the role of education, Alkem hopes to educate patients in India about the need to manage their asthma effectively through these camps.
An Alkem spokesperson said, “We have engaged with over 500 camps since the start of our campaign. This year, we’re organizing at least 600 camps and clinics to raise awareness about asthma and its management. Our goal is to empower patients with the knowledge they need to take control of their health.”
The Reliever Free India campaign aims to educate patients, healthcare professionals, and the public about the benefits of controller medications in preventing asthma symptoms and reducing the need for rescue medication. Alkem Laboratories invites everyone to join hands in raising awareness, fostering understanding, and empowering individuals with asthma to live their lives to the fullest.
